Search research articles
Contact Us
Filters
Showing results (211-220 of 222) with videos related to
Page
of 23
Sort By:
Lymphatic Research and Biology
|
March 22, 2017
Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema
Paula M C Donahue, Rachelle Crescenzi, Allison O Scott, et al.
Lymphatic Research and Biology
|
March 26, 2026
Tissue Sodium Response to Complete Decongestive Therapy in Lower Extremity Lymphedema
Shannon L Taylor, Vanessa N Crain, Paula M C Donahue, et al.
Lancet (London, England)
|
July 4, 1998
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study
J Burn, P Brennan, J Little, et al.
BMC Pharmacology
|
August 18, 2010
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonist
John R Hadcock, Philip A Carpino, Philip A Iredale, et al.
Lymphatic Research and Biology
|
June 13, 2026
<sup>23</sup>Na-MRI Measures Tissue Sodium in Human Leg Lymphedema
Shannon L Taylor, Vanessa N Crain, Sheau-Chiann Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2006
Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats
Kimberly O Cameron, Bruce A Lefker, Margaret Y Chu-Moyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 7, 2006
A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats
Hua Zhu Ke, D Todd Crawford, Hong Qi, et al.
Genetics
|
July 24, 2019
Using a Robust and Sensitive GFP-Based cGMP Sensor for Real-Time Imaging in Intact <i>Caenorhabditis elegans</i>
Sarah Woldemariam, Jatin Nagpal, Tyler Hill, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2026
Discovery of Triazine-Based Toll-Like Receptor 9 Antagonists with Oral Activity
Michael D Mandler, Yeheng Zhu, Emily C Hollenbeck, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2005
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists
Philip A Carpino, David A Griffith, Subas Sakya, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 222) with videos related to
Sort By:
Page
of 23
Lymphatic Research and Biology
|
March 22, 2017
Bilateral Changes in Deep Tissue Environment After Manual Lymphatic Drainage in Patients with Breast Cancer Treatment-Related Lymphedema
Paula M C Donahue, Rachelle Crescenzi, Allison O Scott, et al.
Lymphatic Research and Biology
|
March 26, 2026
Tissue Sodium Response to Complete Decongestive Therapy in Lower Extremity Lymphedema
Shannon L Taylor, Vanessa N Crain, Paula M C Donahue, et al.
Lancet (London, England)
|
July 4, 1998
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study
J Burn, P Brennan, J Little, et al.
BMC Pharmacology
|
August 18, 2010
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) receptor antagonist
John R Hadcock, Philip A Carpino, Philip A Iredale, et al.
Lymphatic Research and Biology
|
June 13, 2026
<sup>23</sup>Na-MRI Measures Tissue Sodium in Human Leg Lymphedema
Shannon L Taylor, Vanessa N Crain, Sheau-Chiann Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2006
Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats
Kimberly O Cameron, Bruce A Lefker, Margaret Y Chu-Moyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 7, 2006
A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats
Hua Zhu Ke, D Todd Crawford, Hong Qi, et al.
Genetics
|
July 24, 2019
Using a Robust and Sensitive GFP-Based cGMP Sensor for Real-Time Imaging in Intact <i>Caenorhabditis elegans</i>
Sarah Woldemariam, Jatin Nagpal, Tyler Hill, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2026
Discovery of Triazine-Based Toll-Like Receptor 9 Antagonists with Oral Activity
Michael D Mandler, Yeheng Zhu, Emily C Hollenbeck, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2005
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists
Philip A Carpino, David A Griffith, Subas Sakya, et al.
Page
of 23